Journey Medical Corp (DERM)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

6 annual periodsNewest to oldest
202520242023202220212020
Revenue$61.2M$55.1M$59.7M$71.0M$63.1M$44.5M
Research & development$480,000$9.9M$7.5M$10.9M$2.7M
Operating income−$8.2M−$13.7M−$2.1M−$27.5M−$34.9M$7.9M
EBITDAderived−$34.9M$7.9M
Net income−$11.4M−$14.7M−$3.9M−$29.6M−$44.0M$5.3M
Basic EPSper diluted share-$0.47-$0.72-$0.21-$1.69-$4.32$0.58
Diluted EPSper diluted share-$0.47-$0.72-$0.21-$1.69-$4.32$0.49

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)12$960.1K disclosed value
12 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 2, 2025Form 4Maraoui ClaudePresident & CEOSellCommon Stock, $0.0001 par value4.8K$6.84$33.1K2.35M
May 2, 2025Form 4Benesch JosephCFOSellCommon Stock, $0.0001 par value2.4K$6.84$16.5K203.6K
May 2, 2025Form 4Alloush RamseyCOOSellCommon Stock, $0.0001 par value2.9K$6.84$19.5K504.8K
Mar 11, 2025Form 4Maraoui ClaudePresident & CEOSellCommon Stock, $0.0001 par value49.3K$5.01$246.8K2.00M
Mar 7, 2025Form 4Maraoui ClaudePresident & CEOSellCommon Stock, $0.0001 par value14.9K$5.01$74.7K2.05M